Treatment with 670 nm Light Up Regulates Cytochrome C Oxidase Expression and Reduces Inflammation in an Age-Related Macular Degeneration Model

Begum, Rana; Powner, Michael B.; Hudson, Natalie; Hogg, Chris; Jeffery, Glen
February 2013
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
Academic Journal
Inflammation is an umbrella feature of ageing. It is present in the aged retina and many retinal diseases including age-related macular degeneration (AMD). In ageing and in AMD mitochondrial function declines. In normal ageing this can be manipulated by brief exposure to 670 nm light on the retina, which increases mitochondrial membrane potential and reduces inflammation. Here we ask if 670 nm exposure has the same ability in an aged mouse model of AMD, the complement factor H knockout (CFH−/−) where inflammation is a key feature. Further, we ask whether this occurs when 670 nm is delivered briefly in environmental lighting rather than directly focussed on the retina. Mice were exposed to 670 nm for 6 minutes twice a day for 14 days in the form of supplemented environmental light. Exposed animals had significant increase in cytochrome c oxidase (COX), which is a mitochondrial enzyme regulating oxidative phosphorylation.There was a significant reduction in complement component C3, an inflammatory marker in the outer retina. Vimetin and glial fibrillary acidic protein (GFAP) expression, which reflect retinal stress in Muller glia, were also significantly down regulated. There were also significant changes in outer retinal macrophage morphology. However, amyloid beta (Aβ) load, which also increases with age in the outer retina and is pro-inflammatory, did not change. Hence, 670 nm is effective in reducing inflammation probably via COX activation in mice with a genotype similar to that in 50% of AMD patients even when brief exposures are delivered via environmental lighting. Further, inflammation can be reduced independent of Aβ. The efficacy revealed here supports current early stage clinical trials of 670 nm in AMD patients.


Related Articles

  • AAV-mediated expression of human PRELP inhibits complement activation, choroidal neovascularization and deposition of membrane attack complex in mice. Birke, M T; Lipo, E; Adhi, M; Birke, K; Kumar-Singh, R // Gene Therapy;May2014, Vol. 21 Issue 5, p507 

    Age-related macular degeneration (AMD) is the leading cause of blindness among the elderly. Approximately 50% of AMD patients have a polymorphism in the negative regulator of complement known as Factor H. Individuals homozygous for a Y402H polymorphism in Factor H have elevated levels of...

  • An Eye on Age-Related Macular Degeneration: The Role of MicroRNAs in Disease Pathology. Berber, Patricia; Grassmann, Felix; Kiel, Christina; Weber, Bernhard // Molecular Diagnosis & Therapy;Feb2017, Vol. 21 Issue 1, p31 

    Age-related macular degeneration (AMD) is the primary cause of blindness in developed countries, and is the third leading cause worldwide. Emerging evidence suggests that beside environmental and genetic factors, epigenetic mechanisms, such as microRNA (miRNA) regulation of gene expression, are...

  • Differential Alterations in the Expression of Neurotransmitter Receptors in Inner Retina following Loss of Photoreceptors in rd1 Mouse. Srivastava, Prerna; Sinha-Mahapatra, Sumit K.; Ghosh, Abhinaba; Srivastava, Ipsit; Dhingra, Narender K. // PLoS ONE;Apr2015, Vol. 10 Issue 4, p1 

    Loss of photoreceptors leads to significant remodeling in inner retina of rd1 mouse, a widely used model of retinal degeneration. Several morphological and physiological alterations occur in the second- and third-order retinal neurons. Synaptic activity in the excitatory bipolar cells and the...

  • New treatments may usher new era for AMD patients. Groves, Nancy // Ophthalmology Times;4/15/2006, Vol. 31 Issue 8, p34 

    The article discusses the new treatment options for age-related macular degeneration (AMD). According to Michael Tolentino, director of clinical research, several pharmacologic options for the disease are created to block different steps in the angiogenic cascade in the diverse stages of...

  • Late AMD represents potential public health problem. Charters, Lynda; Klein, Ronald // Ophthalmology Times;8/1/2006, Vol. 31 Issue 15, p19 

    The article discusses the results of the Beaver Dam Eye Study in the U.S. revealing that patients with age-related macular degeneration (AMD) who have a few small, hard drusen have little risk of progression to advanced stages of AMD over a 15-year period. Patients with large areas of drusen had...

  • Living with Age-Related Macular Degeneration. Backman, Howard; Williams, Ruth // Journal of Visual Impairment & Blindness;May2002, Vol. 96 Issue 5, p345 

    Presents a study which identified the causes and effects of the age-related macular degeneration (AMD). Occurrence of AMD; Risk factors for AMD; Effect of visual problem on lifestyle and emotions.

  • Nutritional supplement helps improves vision in age-related macular degeneration, finds study.  // Ophthalmology Times;10/1/2008, Vol. 33 Issue 19, p36 

    The article reports on the findings of a study which found that nutritional supplement helps improves vision in age-related macular degeneration in Houston, Texas. It was revealed that a combination of antioxidants and micronutrients helps patients improve their vision. Information on how the...

  • Choroidal neovascularization is inhibited via an intraocular decrease of inflammatory cells in mice lacking complement component C3. Tan, Xue; Fujiu, Katsuhito; Manabe, Ichiro; Nishida, Junko; Yamagishi, Reiko; Nagai, Ryozo; Yanagi, Yasuo // Scientific Reports;10/30/2015, p15702 

    In early age-related macular degeneration (AMD), complement component C3 can be observed in drusen, which is the accumulation of material beneath the retinal pigment epithelium. The complement pathways, via the activation of C3, can upregulate the expression of cytokines and their receptors and...

  • Lentiviral gene replacement therapy of retinas in a mouse model for Usher syndrome type 1B. Hashimoto, T.; Gibbs, D.; Lillo, C.; Azarian, S. M.; Legacki, E.; Zhang, X.-M.; Yang, X.-J.; Williams, D. S. // Gene Therapy;Apr2007, Vol. 14 Issue 7, p584 

    One of the most disabling forms of retinal degeneration occurs in Usher syndrome, since it affects patients who already suffer from deafness. Mutations in the myosin VIIa gene (MYO7A) cause a major subtype of Usher syndrome, type 1B. Owing to the loss of function nature of Usher 1B and the...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics